As you can see in our PCMs algorithm, those who have a Gleason score of less than or equal to 7 (3+4) should receive a Decipher BiopsyOncotypeDX or Prolaris test. These tests analyze specific genes that, when tested, have the ability to show if  certain low to intermediate grade prostate cancers have may have the potential to behave more aggressively, and will allow your health care provider to determine if active surveillance or further treatment is necessary. There are many factors that contribute to the outcome of these tests; only you and your health care provider should decide what steps to take.  Click Here to return to the home page.